Efficacy of continuous zanubrutinib vs fixed-duration venetoclax in combination with obinutuzumab in treatment-naive (TN) chronic lymphocytic leukemia (CLL): A matching-adjusted indirect comparison (MAIC)

No Thumbnail Available

All Authors

Munir,Talha
Yang,Keri
Mohseninejad,Leyla
Xu,Sheng
Rakonczai,Pal
Dobi,Balazs
Williams,Rhys
Martinez-Calle,Nicolas

LTHT Author

Munir, Talha

LTHT Department

Oncology
Haematology

Non Medic

Publication Date

2025

Item Type

Article

Language

Subject

Subject Headings